2 mil cheap shares handed over to patient holders at 4c and 4.1c.
All good. Be prepared to see re-rate in coming days and weeks. Good news WONT be lost on smart investors.
Q2 revenue is now firmly around $4.5mil (April = $1.2mil, May = $1.44mil, June = approximately average $62k/day = $1.86mil). That is 134% growth on Q1.
Also, dont be surprised Ted team will smash the $65k/day target by the end of June. Look like they may smash $70k/day soon IMO. Q3 and Q4 are now looking to be new records since IPO.
I only work on numbers. I dont work on sentiment or on figures that some trolls pluck off a tree or out of the air. Numbers dont lie and sp will follow the numbers eventually.
EN1 Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held